You have 9 free searches left this month | to do more
Showing 1 - 25 of
365 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Leiomyosarcoma
Recruiting
  • Leiomyosarcoma
  • Santa Monica, California
    Sant P Chawla
2021-09-09
Sep 9, 2021
U
Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma
Recruiting
  • Classical Hodgkin Lymphoma
  • Dacarbazine
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-03-10
Mar 10, 2022
P
A Study of Unesbulin (PTC596) in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS)
Recruiting
  • Leiomyosarcoma
  • Jacksonville, Florida
  • +4 more
2022-03-14
Mar 14, 2022
S
CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma
Recruiting
  • LMS - Leiomyosarcoma
  • Uterine Leiomyosarcoma
  • Stanford, California
    Stanford University
2022-02-11
Feb 11, 2022
N
Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma - 2011
Completed
Has Results
  • Malignant Melanoma
  • Recurrent Melanoma
  • Dacarbazine
  • +2 more
  • (no location specified)
2020-10-18
Oct 18, 2020
N
Impact of O6-methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and MGMT Expression on Dacarbazine Treated Sarcoma Patients (MGMT)
Active, not recruiting
  • Sarcoma
  • O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and MGMT expression on dacarbazine treated sarcoma patients
  • Naples, Campania, Italy
    National Cancer Institute of Naples
2021-05-14
May 14, 2021
U
Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients
Active, not recruiting
  • Metastatic Melanoma
  • Proleukin and Dacarbazine
  • Louisville, Kentucky
    James Graham Brown Cancer Center
2021-10-22
Oct 22, 2021
M
Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma - 2010
Completed
Has Results
  • Melanoma
  • PI-88 and dacarbazine
  • dacarbazine or DTIC
  • Tucson, Arizona
  • +11 more
2020-12-29
Dec 29, 2020
P
A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)
Not yet recruiting
  • Leiomyosarcoma
  • (no location specified)
2022-02-25
Feb 25, 2022
I
Study With Trabectedin Versus Adriamycin Plus Dacarbazine, in Patients With Advanced Solitary Fibrous Tumor
Recruiting
  • Solitary Fibrous Tumors
  • Prato, Firenze, Italy
  • +5 more
2021-10-29
Oct 29, 2021
C
Safety and Efficacy of DCB-BO1301 in Advanced Melanoma
Not yet recruiting
  • Advanced Melanoma
  • (no location specified)
2022-03-17
Mar 17, 2022
S
A Phase Ⅲ Study to Investigate Toripalimab Versus Dacarbazine as the First Line Therapy for Unresectable or Metastatic Melanoma
Recruiting
  • Metastatic Melanoma
  • Unresectable Melanoma
  • JS001 240mg Q2W
  • Dacarbazine 1000mg/m2 Q3W
  • Beijing, Beijing, China
  • +2 more
2020-09-28
Sep 28, 2020
T
A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma - 2021
Completed
Has Results
  • Hodgkin Disease
  • Brentuximab vedotin
  • +3 more
  • Aurora, Colorado
  • +13 more
2021-10-01
Oct 1, 2021
U
Preconditioning of Tumor, Tumor Microenvironment and the Immune System to Immunotherapy
Recruiting
  • Immunotherapy
  • Dacarbazine (DTIC)
  • Erlangen, Bavaria, Germany
    University Hospital
2021-01-13
Jan 13, 2021
B
A Comparative Study in Chinese Subjects With Chemotherapy Naïve Stage IV Melanoma Receiving Ipilimumab (3 mg/kg) vs. Dacarbazine - 2019
Completed
Has Results
  • Melanoma
  • Nanjing, Jiangsu, China
  • +7 more
2020-05-05
May 5, 2020
F
R-ABVD vs ABVD-RT in Early Stage Hodgkin's Lymphoma - 2019
Terminated
  • Hodgkin Lymphoma
  • Houston, Texas
  • +10 more
2021-08-18
Aug 18, 2021
C
Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers - 2012
Completed
  • Stage IV Melanoma
  • recombinant interferon alfa-2b
  • +4 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Institute, Case Comprehensive Cancer Ce
2020-07-22
Jul 22, 2020
S
First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)
Recruiting
  • Hodgkin Lymphoma, Adult
  • Moscow, Russian Federation
    The Federal Budget-Funded Institution National Medical Surgical
2020-11-20
Nov 20, 2020
U
Nivolumab and AVD in Early-stage Unfavorable Classical Hodgkin Lymphoma
Active, not recruiting
  • Classical Hodgkin Lymphoma
  • Cologne, Germany
    University Hospital of Cologne
2021-04-06
Apr 6, 2021
N
Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma - 2015
Completed
Has Results
  • Melanoma
  • Los Angeles, California
  • +18 more
2020-12-08
Dec 8, 2020
N
Comparison of Melatonin or Metformin and Dacarbazine Combination Versus Dacarbazine Alone in Disseminated Melanoma - 2018
Terminated
  • Melanoma
  • St. Petersburg, Russian Federation
  • +2 more
2019-11-22
Nov 22, 2019
P
Efficacy and Safety of L19TNF in Previously Treated Patients With Advanced Stage or Metastatic Soft-tissue Sarcoma
Recruiting
  • Soft Tissue Sarcoma
  • Dacarbazine
  • onfekafusp alfa
  • Münster, Germany
    Münster University Hospital
2022-03-16
Mar 16, 2022
B
Study of Nivolumab (BMS-936558) Compared With Dacarbazine in Untreated, Unresectable, or Metastatic Melanoma - 2021
Completed
Has Results
  • Melanoma
  • BMS-936558 (Nivolumab)
  • +3 more
  • Capital Federal, Buenos Aires, Argentina
  • +74 more
2021-08-02
Aug 2, 2021
U
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Not yet recruiting
  • Hodgkin Lymphoma
  • Involved site radiotherapy
  • +6 more
  • (no location specified)
2021-09-27
Sep 27, 2021
O
A Clinical Study to Evaluate the Safety and Efficacy of OrienX010 in Unresectable Malignant Melanoma Patients
Recruiting
  • Melanoma (Skin)
  • OrienX010 injection
  • Dacarbazine (DTIC)
  • Beijing, Beijing, China
    Beijing Cancer Hospital
2020-02-25
Feb 25, 2020